Yonhap Infomax NewsOct 28
Samsung Biologics delivered record Q3 earnings, with revenue and profit soaring on full plant utilization, strong biosimilar sales, and favorable FX, beating market forecasts and signaling sustained order growth.
#YonhapInfomax #SamsungBiologics #Q3Earnings #BiosimilarSales #OperatingProfit #OrderGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=87675
Factory Utilization at Full Capacity, Biosimilar Sales Surge—Samsung Biologics Posts Surprise Q3 Earnings Beat (Comprehensive)

Samsung Biologics delivered record Q3 earnings, with revenue and profit soaring on full plant utilization, strong biosimilar sales, and favorable FX, beating market forecasts and signaling sustained order growth.

Yonhap Infomax
Yonhap Infomax NewsAug 8, 2025
Instacart beat Q2 earnings and revenue forecasts, issued a strong Q3 outlook, and saw shares surge nearly 10% in after-hours trading on robust order growth and AI-driven service enhancements.
#YonhapInfomax #Instacart #Q2Earnings #AfterHoursTrading #ArtificialIntelligence #OrderGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=76236
Instacart Posts Strong Q2 Results—Shares Jump 10% in After-Hours Trading

Instacart beat Q2 earnings and revenue forecasts, issued a strong Q3 outlook, and saw shares surge nearly 10% in after-hours trading on robust order growth and AI-driven service enhancements.

Yonhap Infomax